The Pfizer-BioNTech COVID-19 vaccine received authorization for conditional use from the European Commission on December 21. The decision came on the same day that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended authorizing the vaccine.
from Sputnik News - World News, Breaking News & Top Stories https://ift.tt/37Y6VnJ
via IFTTT
No comments:
Post a Comment